Finally, consistent with the previous NSCLC dataset (Supplementary Table 2), GATAD2B copy-number driven expression (****p < 0.0001, t-test, Supplementary Fig. 3a) was higher in KRAS mutant compared to wild type lung adenocarcinomas (n = 517 patients, Wilcoxon rank-sum, p < 0.0350, Fig. 2d). Here, KRAS is linked to non-small cell lung carcinoma.